Skip to content

CancerIndexthe global index of cancer

Cancers Data Trials Drugs Genes Biomarkers Approvals Rankings Research gap Graph

Cancers Data Trials Drugs Genes Biomarkers Approvals Rankings Research gap Graph

Pulse Data updates Year in cancer Taxonomy Countries Compare Trial intelligence Trial map Drug pipeline Sources Methodology About Trust & policies Data downloads Developers (API)

Loading cancer entity…

CancerIndex

CancerIndex is a research and information platform. It is not a physician, does not diagnose, and does not recommend treatment. Population statistics do not predict individual outcomes.

Every number links to its source and retrieval date. Derived metrics carry a formula version. AI-generated synthesis is not enabled in this phase; all content is database-grounded.

About Trust & policies Data explorer Data downloads Pulse Data update log Developers (API)Sources Methodology Taxonomy Countries Compare Contact · contact@spboucher.ai Status

© 2026 CancerIndex · built and maintained by Simon-Pierre Boucher · contact contact@spboucher.ai · hosted on MacLustr (www.maclustr.io). Source data remains under the license of each provider — see /sources.

Papillary Epithelial Neoplasm — Research · CancerIndex

Cancers
Neoplasm
Neoplasm by Morphology
Epithelial Neoplasm
Papillary Epithelial Neoplasm

Cancer Family

Papillary Epithelial Neoplasm

CI-CAN-00000311Explore in graph →

Non-malignant70 active trials23 evidence items

NCIt: C8429

Overview
Statistics
Survival
Genomics12
Variants & evidence23
Drugs6
Trials281
Research
Rankings
Sources & provenance

Research activity

PubMed record counts

Each count is the number of PubMed records returned by the exact query shown, at the time it was run. Counts are research-activity signals, not quality measures.

Data not yet available

No PubMed query has been run for this entity. Counts require a MeSH-anchored query built from the entity's terminology mappings; the query string is stored with each count so it can be reproduced.

What CancerIndex knows

Trials tab
Methodology: publication counts

Literature

Linked publications (22)

Publications linked to this entity or its descendants, newest first, 25 per page. Link method and validation status are shown; 'candidate' links have not been reviewed.

pubmedProvenance

Source: PubMed (NLM)
Dataset: PubMed E-utilities
Retrieved: Sep 8, 2026
Layer: normalized (units and labels harmonized; values unchanged)

PublishedShowing 1–22 of 22 publications · bibliographic data as recorded by PubMed; abstracts are not reproduced.

Immunohistochemistry for BRAF(V600E) antibody VE1 performed in core needle biopsy samples identifies mutated papillary thyroid cancers.
· Horm Metab Res · 2014 · PMID 24570209 · validated civic_curation pubmed
The BRAF(V600E) mutation in papillary thyroid microcarcinoma: does the mutation have an impact on clinical outcome?
· Clin Endocrinol (Oxf) · 2014 · PMID 24354346 · validated civic_curation pubmed
BRAF V600E and TERT promoter mutations cooperatively identify the most aggressive papillary thyroid cancer with highest recurrence.
· J Clin Oncol · 2014 · PMID 25024077 · validated civic_curation pubmed
Oncogenic AKAP9-BRAF fusion is a novel mechanism of MAPK pathway activation in thyroid cancer.
· J Clin Invest · 2005 · PMID 15630448 · validated civic_curation pubmed
BRAF(V600E) mutation and outcome of patients with papillary thyroid carcinoma: a 15-year median follow-up study.
· J Clin Endocrinol Metab · 2008 · PMID 18682506 · validated civic_curation pubmed
Vemurafenib in patients with BRAF(V600E)-positive metastatic or unresectable papillary thyroid cancer refractory to radioactive iodine: a non-randomised, multicentre, open-label, phase 2 trial.
· Lancet Oncol · 2016 · PMID 27460442 · validated civic_curation pubmed
BRAF mutation predicts a poorer clinical prognosis for papillary thyroid cancer.
· J Clin Endocrinol Metab · 2005 · PMID 16174717

Showing 1–22 of 22 publications

· validated civic_curation

Both BRAF V600E mutation and older age (≥ 65 years) are associated with recurrent papillary thyroid cancer.

· Ann Surg Oncol · 2011 · PMID 21594703 · validated civic_curation pubmed

Prognostic value of the BRAF V600E mutation in papillary thyroid carcinoma.

· Oncol Lett · 2014 · PMID 24396464 · validated civic_curation pubmed

Phase II and biomarker study of the dual MET/VEGFR2 inhibitor foretinib in patients with papillary renal cell carcinoma.

· J Clin Oncol · 2013 · PMID 23213094 · validated civic_curation pubmed

Programmed death-ligand 1 overexpression is a prognostic marker for aggressive papillary thyroid cancer and its variants.

· Oncotarget · 2016 · PMID 27086918 · validated civic_curation pubmed

The association of the BRAF(V600E) mutation with prognostic factors and poor clinical outcome in papillary thyroid cancer: a meta-analysis.

· Cancer · 2012 · PMID 21882184 · validated civic_curation pubmed

NTRK fusion oncogenes in pediatric papillary thyroid carcinoma in northeast United States.

· Cancer · 2016 · PMID 26784937 · validated civic_curation pubmed

Extended Antitumor Response of a BRAF V600E Papillary Thyroid Carcinoma to Vemurafenib.

· Case Rep Oncol · 2014 · PMID 24987354 · validated civic_curation pubmed

Evolution of an adenocarcinoma in response to selection by targeted kinase inhibitors.

· Genome Biol · 2010 · PMID 20696054 · validated civic_curation pubmed

Application of genomics to identify therapeutic targets in recurrent pediatric papillary thyroid carcinoma.

· Cold Spring Harb Mol Case Stud · 2018 · PMID 29610391 · validated civic_curation pubmed

An impressive response with larotrectinib in a patient with a papillary thyroid carcinoma harboring an SQSTM1-NTRK1 fusion.

· Eur J Endocrinol · 2022 · PMID 35118995 · validated civic_curation pubmed

Clinicopathologic and molecular characterization of NTRK-rearranged thyroid carcinoma (NRTC).

· Mod Pathol · 2020 · PMID 32457407 · validated civic_curation pubmed

Raja et al, Cancer 2018

· 2018 · PMID 30427539 · validated cbioportal_study pubmed

Nicolas A et al. Clin Cancer Res 2022

· 2022 · PMID 36228155 · validated cbioportal_study pubmed

Maolan Li et al. Nat Genet 2014

· 2014 · PMID 24997986 · validated cbioportal_study pubmed

TCGA, Cell 2014

· 2014 · PMID 25417114 · validated cbioportal_study pubmed